Stay updated on Nivolumab Radiotherapy Combo in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Radiotherapy Combo in Advanced Melanoma Clinical Trial page.

Latest updates to the Nivolumab Radiotherapy Combo in Advanced Melanoma Clinical Trial page
- Check3 days agoChange DetectedThe footer’s displayed ClinicalTrials.gov revision changed from v3.7.2 to v3.8.0. The page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAn NIH-wide notice about using “Super Intelligence” in place of “Artificial Intelligence” appears above the unavailable study record, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check31 days agoChange DetectedThe footer revision label updates from v3.7.0 to v3.7.1 while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check45 days agoChange DetectedThe NCT02799901 study page now shows a 403 Forbidden error instead of the study details. The content and navigation are replaced by a generic access-denied screen.SummaryDifference18%

- Check52 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This reflects a deployment/version update rather than a modification to the study information presented.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page no longer lists the MeSH term 'Melanoma' and the 'related topics' section including 'MedlinePlus Genetics', reducing the amount of contextual topic information shown for the study.SummaryDifference0.2%

Stay in the know with updates to Nivolumab Radiotherapy Combo in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Radiotherapy Combo in Advanced Melanoma Clinical Trial page.